Health Care/Hospital

Bactiguard Recruits Experienced Chief Medical and Technology Officer

STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his...

2019-09-05 14:41 1291

ZEISS Showcases New CIRRUS 6000 OCT System at the European Society of Retina Specialists 2019 Congress

The ZEISS CIRRUS 6000, 100kHz OCT system promises to dramatically elevate the efficiency of eye care practices.  PARIS, Sept. 5, 2019 /PRNewswire/ -- ZEISS Medical Technology Segment expands its *CIRRUS® — the most trusted Optical Coherence Tomography (OCT) with the launch of its new CIRRUS 600...

2019-09-05 14:00 1300

New FDI World Dental Federation Care Pathway Promotes Dentist-patient Collaboration to Manage Partial Tooth Loss

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- Today during the ADA FDI World Dental Congress inSan Francisco, USA, FDI World Dental Federation (FDI) released its latest resources on the treatment and care of patients with partial tooth loss. Rather than losing all their teeth as they age, more an...

2019-09-05 14:00 1533

Berkeley Lights Opens Shanghai Location

- Nobel Laureate, Professor James E. Rothman, PhD, to speak at all-day symposium onSeptember 5th - China Rep Office located in one of China's leading high-tech industry clusters SHANGHAI and EMERYVILLE, California, Sept. 5, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader ...

2019-09-05 08:06 1208

CROMSOURCE Continues US Growth With New Office in Research Triangle Park

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...

2019-09-04 21:00 1191

Frost & Sullivan Recognizes Validic™ as the North America Customer Value Leader in the Remote Patient Monitoring Market

SANTA CLARA, California, Sept. 4, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote patient monitoring (RPM) market, Frost & Sullivan recognizesValidic™ with the 2019 North America Customer Value Leadership Award for best meeting the current and future market needs fo...

2019-09-04 21:00 1283

IDTechEx Research: The Future of Wearables is Medical

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Wearable technology and medical devices have many prominent synergies. Electronic devices on the body are perfectly placed for sensors to collect data relevant to healthcare, with communication options allowing them to be the gateway to digital health data. C...

2019-09-04 10:00 1844

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

LAVAL, France, Sept. 4, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space.     The expansion integrates Porsolt's new areas of...

2019-09-04 00:03 1509

Renowned Entrepreneur Per Jacob Solli Heads Group Acquiring Canary Island Land Parcel for World's Largest Sustainability-Focused Medical and Sports Resort

Backers Include Leading Global Sports, Music Figures; Gran Canaria to See Infrastructure, Job, Economic Growth GRAN CANARIA, Spain and BEVERLY HILLS, California, Sept. 3, 2019 /PRNewswire/ -- In western Gran Canaria, one ofSpain's Canary Islands off the coast of North Africa, Kokoon Global has a...

2019-09-03 22:25 1426

Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe

BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totalingCHF 2.82 Million from private investors. These funds will enable ...

2019-09-03 14:00 2112

Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine

GDAŃSK, Poland, Sept. 3, 2019 /PRNewswire/ -- Polpharma Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar. The medicine is currently in Phase III clinical development for the treatment of re...

2019-09-03 13:15 1910

The First Asia Pacific Psychiatry Symposium Takes Place

NANJING, China, Sept. 3, 2019 /PRNewswire/ -- The first-ever Asia Pacific Psychiatric Conference hosted by the Luye Pharma Group recently took place in Nanjing. Dozens of psychiatrists and experts from 8 countries and regions includingChina, Korea, Malaysia, and Thailand gathered at the conference...

2019-09-03 12:44 2330

Metrasens Celebrates the Grant of Further Patent for Its Global MRI Safety Business

MALVERN, England, Sept. 3, 2019 /PRNewswire/ -- Metrasens, a leading provider of advanced magnetic detection technologies, is proud to announce today the further strengthening of its patent portfolio through the grant of a new patent by the US Patent office. This patent protects technology that r...

2019-09-03 11:33 2178

International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk

MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...

2019-09-03 07:44 2021

Study Shows BioCell Collagen® Can Visibly Reduce Common Signs of Skin Aging Within 12 Weeks

New peer-reviewed, published research finds that daily use of the dietary ingredient BioCell Collagen® can visibly reduce facial lines and crow's feet wrinkles and boost skin elasticity IRVINE, California, Sept. 3, 2019 /PRNewswire/ -- In one of the most substantial studies of a skin health supp...

2019-09-03 07:22 1826

Children's Lives Will Be Saved Due to Invention of Simple Water Treatment System "Aquatabs Flo"

WEXFORD, Ireland, Sept. 2, 2019  /PRNewswire/ -- The world famous medical journalThe Lancet has published the results of a two year health impact trial in Bangladesh. Less than 5% of studies submitted to this peer reviewed journal are published.  

2019-09-02 21:59 2384

BEGO expands in China by partnering with CareCapital

BREMEN, Germany and HONG KONG, Sept. 2, 2019 /PRNewswire/ -- To better serve clinicians in the fast-growing Chinese dental implant market, BEGO Implant Systems GMBH & CO. KG ("BIS") has signed a strategic partnership agreement covering theChina market with an affiliate of CareCapital Dental Holdi...

2019-09-02 09:26 2571

KSrelief Launches "Response" Initiative to Provide Treatment for Yemenis Injured in Recent Events in Aden and Abyan

RIYADH, Saudi Arabia, Sept. 2, 2019 /PRNewswire/ -- According to a statement issued today by King Salman Humanitarian Aid and Relief Centre (KSrelief), the center "is following with keen interest the unfortunate recent events in the governorates of Aden and Abyan during which many people have bee...

2019-09-02 07:02 1781

Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China

- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...

2019-08-30 22:28 2270

Innovent Biologics Study Results of IBI303 in Patients with Ankylosing Spondylitis was Published in "The Lancet Rheumatology"

SUZHOU, China, Aug. 30, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical trial results of IBI303, an anti-tumor necrosis factor-alpha (anti-TNF...

2019-08-30 17:38 3085
1 ... 224225226227228229230 ... 435